ACCESS! 2026 Day 2 Recap
ACCESS! 2026 Day 2 Recap: New Leadership, Hard Data, and a View from the Top After a memorable first evening capped by a Candlelight by Fever performance that traded policy debates for strings and candlelight, ACCESS! 2026 attendees returned to the plenary hall Wednesday morning energized and ready for a second day packed with substance. […]
ACCESS! 2026 Day 1 Recap
ACCESS! 2026 Day 1 Recap: Weathering Every Storm to Protect Patient Access Leaders and luminaries in the generic and biosimilars community descended on Miami for the opening day of ACCESS! 2026, many having braved a historic blizzard slamming the Northeast to reach the sunshine. While the determination of those who made it underscored the industry’s […]
GRx+Biosims 2025 Day 3 Recap: Passion Manifests In Progress
The final day of GRx+Biosims was a rewarding day of excitement for all participants. If Day 1 was about passion and purpose, and Day 2 about putting that passion into practice, Day 3 delivered on the promise of progress. It was a milestone day – one that united leadership, science, and policy in tangible action. […]
GRx+Biosims 2025 Day 2 Recap: From Passion to Progress
If Day 1 was about rekindling purpose, Day 2 was about putting it into motion. The morning opened with the same buzz of momentum with hallway conversations still circling around collaboration, patient access, and sustainability. The tone quickly turned from celebration to introspection. Speakers reminded the audience that the true test of this community’s purpose […]
GRx+Biosims 2025 Day 1 Recap: Bringing Passion to Purpose
The first day of the 2025 GRx+Biosims Conference set an energetic tone for the days ahead full of optimism, urgency, and shared purpose. With a patient-centric message that echoed a recurring theme of “bringing passion to purpose,” speakers reminded attendees that behind every regulation, every manufacturing milestone, and every patent debate is the same mission: […]
Access! 2025 Recap: A Call to Action for the Future of Generics and Biosimilars
The second and final day of Access! 2025 reinforced the urgency of addressing the challenges facing the generics and biosimilars industry. Amid growing political scrutiny, regulatory uncertainty, and shifting market dynamics, speakers and panelists highlighted the industry’s vital role in ensuring access to affordable medicines. From biosimilar adoption and PBM reform to FDA regulatory risks […]
ACCESS! 2025 Day 1 Recap
ACCESS! 2025 Day 1 Recap: Meeting the Moment and Navigating Uncertainty The opening day of Access! 2025 set the stage for an urgent and forward-looking discussion on the state of the generics and biosimilars industry. Against the backdrop of major news events—including the Trump administration’s proposed and paused tariffs, and Robert F. Kennedy Jr.’s nomination […]
GRx+Biosims 2024 Conference Recap
The GRx+Biosims 2024 conference, recently held in Rockville, Maryland, brought together stakeholders from across the pharmaceutical, healthcare, and regulatory landscapes to discuss the transformative potential of generic and biosimilar medicines. With a shared commitment to improving patient access to high-quality, affordable treatments, the conference provided an essential platform for engaging in dynamic discussions about policy, […]
GRx+Biosims 2023 Conference Recap
GRx+Biosims 2023, the highly anticipated conference for the generics and biosimilars industry, recently concluded in North Bethesda, Maryland. The event served as a platform for in-depth discussions led by prominent experts and key figures from both the government and industry sectors. Over the course of three days, critical conversations unfolded, paving the way for significant […]
Back Together: GRx+Biosims 2022 Conference Recap
For the first time in three years, GRx+Biosims – the premier scientific and regulatory event for the generics and biosimilars industry – convened in North Bethesda, Maryland. Bringing together top experts and leaders in government and industry, the three-day event featured important conversations that will shape the future of our industry and help secure greater […]
Access! 2022: Recapping AAM’s Annual Meeting
Access is literally our middle name, CEO Dan Leonard reminded attendees at Access! 2022, the Association for Accessible Medicine’s first in-person conference in two years. The two-day event in Orlando, Fla., brought together a range of leaders from government and industry to discuss the challenges, responsibilities and future of generics and biosimilars. In his remarks […]
Process & Progress: A Recap of GRx+Biosims 2021
November 8-10, 2021, the Association for Accessible Medicines (AAM) and its Biosimilars Council hosted GRx+Biosims 2021, the premier scientific and regulatory event for the U.S. generics and biosimilars industry. The theme of this year’s virtual conference was “Process & Progress,” telling the story of where we are as industry and where we’re headed. Over three […]
